Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Jinarc 15mg tablets
0605020Y0BCAAAA
|
Jinarc | Tolvaptan | Endocrine System | No data available |
|
Jinarc 30mg tablets
0605020Y0BCABAB
|
Jinarc | Tolvaptan | Endocrine System | No data available |
|
Jinarc 45mg tablets and Jinarc 15mg tablets
0605020Y0BCACAC
|
Jinarc | Tolvaptan | Endocrine System | No data available |
|
Jinarc 60mg tablets and Jinarc 30mg tablets
0605020Y0BCADAD
|
Jinarc | Tolvaptan | Endocrine System | No data available |
|
Jinarc 90mg tablets and Jinarc 30mg tablets
0605020Y0BCAEAE
|
Jinarc | Tolvaptan | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.